Laparoscopic Assisted Plane Block (LAPB) Trial
common.study.values.description
“Laparoscopic Assisted Plane Block (LAPB) Trial”
This study attempts to demonstrate improvement in analgesia in a more diverse laparoscopic surgery group with the use of laparoscopic assisted transversus abdominis plane blocks. The investigators will compare bupivacaine (treatment arm 1) versus liposomal bupivacaine (treatment arm 2) versus port site injection of local anesthesia with injection of saline placebo (control). The hypothesis is that liposomal bupivacaine will result in improved analgesia when compared to bupivacaine LAPB and control. The investigators further hypothesize that bupivacaine LAPB will be more effective than the control.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - Bupivacaine
utilizing local anesthetic to perform a regional block under laparoscopic guidance
Drug - Exparel 266 milligram Per 20 ML Injection
utilizing local anesthetic to perform a regional block under laparoscopic guidance
Drug - Saline
placebo injection of saline
participant.views.study.view.additional
participant.views.study.view.scientific-title
Laparoscopic Assisted Plane Block (LAPB) Trial: Bupivacaine Versus Liposomal Bupivacaine Versus Standard Local Anesthesia for Post-operative Analgesia
common.study.values.clinical-trial-id
NCT03730402
participant.views.study.view.id
b68m9e
